Indrayani Biotech Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Indrayani Biotech Ltd. on BSE

Search Inside the pdf :

Indrayani Biotech Ltd.

15 Jun 2025

13.65

-1.09%

Company Update

Indrayani Biotech Ltd - 526445 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 we are herewith enclosing a copy of the Newspaper publication pertaining to the Audited FInancial Results (Standaole and Consolidated) for the Quarter and year ended 31st March 2025

pdf

Indrayani Biotech Ltd.

13 Jun 2025

13.65

-1.09%

Company Update

Indrayani Biotech Ltd - 526445 - Outcome Of The Board Meeting Held On 13Th June 2025

BSE India

Outcome of the Board meeting held on 13th June 2025

pdf

Indrayani Biotech Ltd.

13 Jun 2025

13.65

-1.09%

Result

Indrayani Biotech Ltd - 526445 - Audited Consolidated Financial Results For The Quarter And Year Ended …

BSE India

Audited consolidated financial results for the quarter and year ended 31st March 2025 along with report of statutory auditors.

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	53.35	17.32	45.41	208.0%	17.5%
Operating Profit Qtr	-5.74	2.92	10.17	-296.6%	-156.4%
Net Profit Qtr	-8.53	0.35	3.87	-2537.1%	-320.4%
Earning Per Share Adjusted latest Qtr	-1.87	0.08	0.85	-2437.5%	-320.0%

* Consolidated data

Detailed Results

Indrayani Biotech Ltd.

12 Jun 2025

13.65

-1.09%

Company Update

Indrayani Biotech Ltd - 526445 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance …

BSE India

Resignation of V Santhanakrishnan, as Company Secretary and Compliance Officer with effect from 13th June 2025

pdf

Indrayani Biotech Ltd.

12 Jun 2025

13.65

-1.09%

Board Meeting

Indrayani Biotech Ltd - 526445 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

Outcome of Board meeting held on 12th June 2025

pdf

Indrayani Biotech Ltd.

12 Jun 2025

13.65

-1.09%

Result

Indrayani Biotech Ltd - 526445 - Audited Standalone Results For The Quarter And Year Ended 31St …

BSE India

Audited Standalone Financial Results for the quarter and year ended 31st March 2025 along with Audit report

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	53.35	17.32	45.41	208.0%	17.5%
Operating Profit Qtr	-5.74	2.92	10.17	-296.6%	-156.4%
Net Profit Qtr	-8.53	0.35	3.87	-2537.1%	-320.4%
Earning Per Share Adjusted latest Qtr	-1.87	0.08	0.85	-2437.5%	-320.0%

* Consolidated data

Detailed Results

Indrayani Biotech Ltd.

09 Jun 2025

13.65

-1.09%

Company Update

Indrayani Biotech Ltd - 526445 - Board Meeting Intimation for Considering And Approving The Audited Financial …

BSE India

Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2025 ,inter alia, to consider and approve the audited financial results (standalone and consolidated) for the quarter and year ended 31st March 2025

pdf

Indrayani Biotech Ltd.

09 Jun 2025

13.65

-1.09%

Company Update

Indrayani Biotech Ltd - 526445 - Announcement under Regulation 30 (LODR)-Meeting Updates

BSE India

Adjournment of Board meeting and Detailed reasons for delay in submission of audited Financial results (Standalone & Consolidated) for the quarter and year ended 31st March 2025.

pdf

Indrayani Biotech Ltd.

28 May 2025

13.65

-1.09%

Company Update

Indrayani Biotech Ltd - 526445 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Annual Secretarial Compliance Report for the financial year ended 31st March 2025

pdf

Indrayani Biotech Ltd.

27 May 2025

13.65

-1.09%

Result

Indrayani Biotech Ltd - 526445 - Results-Delay in Financial Results

BSE India

Detailed reasons for the delay in submission of audited financial results for the quarter and year ended 31st March 2025 is attached.

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	53.35	17.32	45.41	208.0%	17.5%
Operating Profit Qtr	-5.74	2.92	10.17	-296.6%	-156.4%
Net Profit Qtr	-8.53	0.35	3.87	-2537.1%	-320.4%
Earning Per Share Adjusted latest Qtr	-1.87	0.08	0.85	-2437.5%	-320.0%

* Consolidated data

Detailed Results

Is Indrayani Biotech Ltd. worth buying?

25 Votes:

Buy 72.0%

Sell 12.0%

Hold 16.0%